Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ASENSUS SURGICAL, INC.
Report date August 22, 2024 · Filed August 22, 2024
Section 16 reporting ended · disclosed 2024-08-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-08-22 transaction · row 1
1 source rowRow 1 · 2024-08-22 · Disposition to issuer · Disposed 595,372 · Balance 0 F1: The reported securities were disposed of pursuant to the terms of an Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 6, 2024, by and among Asensus Surgical, Inc., a Delaware corporation ("Asensus"), KARL STORZ Endoscopy-America, Inc., a California corporation ("Parent"), and Karl Storz California Inc., a California corporation ("Merger Sub"), pursuant to which Merger Sub merged with and into Asensus with Asensus as the surviving corporation of the merger (the "Merger"). Upon the effective time of the Merger, the reporting person received $0.35 in cash, without interest and less applicable withholding taxes for each share of common stock. F2: The reported securities include 179,084 shares of common stock issued upon the acceleration and vesting of performance-based restricted stock units. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.26 | Direct | 0 |
Reported balance
After 2024-08-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-22 · Disposition to issuer · Disposed 396,800 · Balance 0 F3: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.09 per underlying share of common stock only upon satisfaction of all vesting conditions. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-08-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-08-22 · Disposition to issuer · Disposed 116,666 · Balance 0 F4: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F6: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-08-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-08-22 · Disposition to issuer · Disposed 62,417 · Balance 0 F4: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F6: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-08-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-22 · Disposition to issuer · Disposed 330,300 · Balance 0 F5: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F6: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-08-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-22 · Disposition to issuer · Disposed 660,600 · Balance 0 F4: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F6: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities were disposed of pursuant to the terms of an Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 6, 2024, by and among Asensus Surgical, Inc., a Delaware corporation ("Asensus"), KARL STORZ Endoscopy-America, Inc., a California corporation ("Parent"), and Karl Storz California Inc., a California corporation ("Merger Sub"), pursuant to which Merger Sub merged with and into Asensus with Asensus as the surviving corporation of the merger (the "Merger"). Upon the effective time of the Merger, the reporting person received $0.35 in cash, without interest and less applicable withholding taxes for each share of common stock.
F2: The reported securities include 179,084 shares of common stock issued upon the acceleration and vesting of performance-based restricted stock units.
F3: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.09 per underlying share of common stock only upon satisfaction of all vesting conditions.
F4: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
F5: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
F6: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions.
Zomedica Corp.
Report date August 14, 2020 · Filed August 14, 2020
Section 16 reporting ended · disclosed 2020-08-14. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2024 Filed Aug 22, 2024 09:08 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Disposition to issuerRestricted Stock Units · Derivative | 660,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-027542 · rdgdoc.xml · derivative · entry 6 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 660,600 shares Expires not disclosed F4 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F6 · security: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.exercise_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.expiration_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 09:08 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Disposition to issuerRestricted Stock Units · Derivative | 330,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-027542 · rdgdoc.xml · derivative · entry 5 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 330,300 shares Expires not disclosed F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F6 · security: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.exercise_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.expiration_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 09:08 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Disposition to issuerRestricted Stock Units · Derivative | 62,417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-027542 · rdgdoc.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,417 shares Expires not disclosed F4 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F6 · security: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.exercise_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.expiration_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 09:08 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Disposition to issuerRestricted Stock Units · Derivative | 116,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-027542 · rdgdoc.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 116,666 shares Expires not disclosed F4 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F6 · security: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.exercise_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. F6 · derivative.expiration_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.35 per underlying share of common stock only upon satisfaction of all vesting conditions. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 09:08 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Disposition to issuerStock Options · Derivative | 396,800 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001437749-24-027542 · rdgdoc.xml · derivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 396,800 shares Expires not disclosed F3 · security: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.09 per underlying share of common stock only upon satisfaction of all vesting conditions. F3 · derivative.exercise_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.09 per underlying share of common stock only upon satisfaction of all vesting conditions. F3 · derivative.expiration_date: Upon the closing of the Merger, these equity awards are cancelled and converted into the contingent right to receive a cash payment of $0.09 per underlying share of common stock only upon satisfaction of all vesting conditions. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 09:08 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Disposition to issuerCommon Stock | 595,372 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-027542 · rdgdoc.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The reported securities were disposed of pursuant to the terms of an Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 6, 2024, by and among Asensus Surgical, Inc., a Delaware corporation ("Asensus"), KARL STORZ Endoscopy-America, Inc., a California corporation ("Parent"), and Karl Storz California Inc., a California corporation ("Merger Sub"), pursuant to which Merger Sub merged with and into Asensus with Asensus as the surviving corporation of the merger (the "Merger"). Upon the effective time of the Merger, the reporting person received $0.35 in cash, without interest and less applicable withholding taxes for each share of common stock. F2 · price: The reported securities include 179,084 shares of common stock issued upon the acceleration and vesting of performance-based restricted stock units. Read SEC document |
| April 21, 2024 Filed Apr 23, 2024 17:47 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 81,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012886 · rdgdoc.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 81,521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F3 · derivative.exercise_date: Lapse of forfeiture restrictions on an award of RSUs granted on April 21, 2023. F3 · derivative.expiration_date: Lapse of forfeiture restrictions on an award of RSUs granted on April 21, 2023. Read SEC document |
| April 21, 2024 Filed Apr 23, 2024 17:47 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Tax withholdingCommon Stock | 43,638 | $0.25 | $10,909.50 |
DisclosureSEC source: 0001437749-24-012886 · rdgdoc.xml · nonDerivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,288 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| April 21, 2024 Filed Apr 23, 2024 17:47 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionCommon Stock | 81,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-012886 · rdgdoc.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 330,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 5 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,300 Underlying: Common Stock · 330,300 shares Expires not disclosed F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F6 · derivative.exercise_date: PRSU award with time-based vesting in three equal installments on each of February 4, 2025, 2026 and 2027, and performance-based vesting only if designated corporate goals are met. F6 · derivative.expiration_date: PRSU award with time-based vesting in three equal installments on each of February 4, 2025, 2026 and 2027, and performance-based vesting only if designated corporate goals are met. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 660,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 660,600 Underlying: Common Stock · 660,600 shares Expires not disclosed F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2025, 2026 and 2027, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2025, 2026 and 2027, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantStock Options · Derivative | 396,800 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,800 Underlying: Common Stock · 396,800 shares Expires 2031-02-06 F2 · derivative.exercise_date: Vests one-third annually on each of February 6, 2025, 2026 and 2027, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement"). Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 58,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 11 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,667 Underlying: Common Stock · 58,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F12 · derivative.exercise_date: Lapse of forfeiture restrictions on the first one-third of one-half of a PRSU award granted on February 3, 2023. One-half of the PRSUs were forfeited upon failure to achieve one of two performance goals. The remaining earned PRSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan ad the Reporting Person's Employment Agreement. F12 · derivative.expiration_date: Lapse of forfeiture restrictions on the first one-third of one-half of a PRSU award granted on February 3, 2023. One-half of the PRSUs were forfeited upon failure to achieve one of two performance goals. The remaining earned PRSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan ad the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 58,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 10 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,666 Underlying: Common Stock · 58,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F11 · derivative.exercise_date: Lapse of forfeiture restrictions on one-third of a RSU award granted on February 3, 2023. Forfeiture restrictions will lapse on the remaining RSUs on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and teh Reporting Person's Employment Agreement. F11 · derivative.expiration_date: Lapse of forfeiture restrictions on one-third of a RSU award granted on February 3, 2023. Forfeiture restrictions will lapse on the remaining RSUs on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and teh Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 62,417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 9 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,417 Underlying: Common Stock · 62,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F10 · derivative.exercise_date: Lapse of forfeiture restrictions on the second one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F10 · derivative.expiration_date: Lapse of forfeiture restrictions on the second one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 62,417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 8 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,417 Underlying: Common Stock · 62,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F9 · derivative.exercise_date: Lapse of forfeiture restrictions on the second one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F9 · derivative.expiration_date: Lapse of forfeiture restrictions on the second one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 19,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 7 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F8 · derivative.exercise_date: Lapse of forfeiture restrictions on third one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. F8 · derivative.expiration_date: Lapse of forfeiture restrictions on third one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 19,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · derivative · entry 6 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F7 · derivative.exercise_date: Lapse of forfeiture on third one-third of an award of RSUs from a grant made on February 8, 2021. F7 · derivative.expiration_date: Lapse of forfeiture on third one-third of an award of RSUs from a grant made on February 8, 2021. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Tax withholdingCommon Stock | 150,367 | $0.27 | $40,599.09 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · nonDerivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,405 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| February 04, 2024 Filed Feb 6, 2024 19:01 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionCommon Stock | 280,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-003268 · rdgdoc.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 528,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 6,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041221 · doc4.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Lapse of forfeiture restrictions on the 6,666 performance-based RSUs from this grant made on August 24, 2020. F4 · derivative.expiration_date: Lapse of forfeiture restrictions on the 6,666 performance-based RSUs from this grant made on August 24, 2020. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041221 · doc4.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents the right to receive one share of the Registrant's common stock. F3 · derivative.exercise_date: Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020. F3 · derivative.expiration_date: Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Tax withholdingCommon Stock | 6,975 | $0.51 | $3,557.25 |
DisclosureSEC source: 0001209191-23-041221 · doc4.xml · nonDerivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,863 Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041221 · doc4.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Lapse of forfeiture restrictions on one third of the grant of the time-based restricted stock units ("RSUs") and on one third of the performance-based RSUs awarded on August 24, 2020. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 18:35 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 81,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025616 · doc4.xml · derivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,521 Underlying: Common Stock · 81,521 shares Expires not disclosed F1 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F2 · derivative.exercise_date: Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. F2 · derivative.expiration_date: Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 62,417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 10 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,833 Underlying: Common Stock · 62,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F11 · derivative.exercise_date: Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on each of February 4, 2024 and 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F11 · derivative.expiration_date: Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on each of February 4, 2024 and 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 62,417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 9 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,833 Underlying: Common Stock · 62,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F10 · derivative.exercise_date: Lapse of forfeiture restrictions on one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024 and 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F10 · derivative.expiration_date: Lapse of forfeiture restrictions on one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024 and 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 19,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 8 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,704 Underlying: Common Stock · 19,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F9 · derivative.exercise_date: Lapse of forfeiture restrictions on second one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F9 · derivative.expiration_date: Lapse of forfeiture restrictions on second one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 19,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 7 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,704 Underlying: Common Stock · 19,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F8 · derivative.exercise_date: Lapse of forfeiture on second one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F8 · derivative.expiration_date: Lapse of forfeiture on second one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 84,270 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 6 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F7 · derivative.exercise_date: Lapse of forfeiture restrictions on discretionary bonus RSUs. F7 · derivative.expiration_date: Lapse of forfeiture restrictions on discretionary bonus RSUs. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Tax withholdingCommon Stock | 103,998 | $0.75 | $77,998.50 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · nonDerivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,172 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionCommon Stock | 248,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 350,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 5 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires not disclosed F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F6 · derivative.exercise_date: PRSU award with time-based vesting in three equal installments on each of February 4, 2024, 2025 and 2026, and performance-based vesting only if designated corporate goals are met. F6 · derivative.expiration_date: PRSU award with time-based vesting in three equal installments on each of February 4, 2024, 2025 and 2026, and performance-based vesting only if designated corporate goals are met. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 175,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires not disclosed F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2024, 2025 and 2026, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2024, 2025 and 2026, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:00 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantStock Options · Derivative | 175,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001209191-23-007655 · doc4.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-02-03 F2 · derivative.exercise_date: Vests one-third annually on each of February 3, 2024, 2025 and 2026, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement"). Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 6,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040851 · doc4.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,666 Underlying: Common Stock · 6,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Lapse of forfeiture restrictions on the 6,667 performance-based RSUs from this grant made on August 24, 2020. F4 · derivative.expiration_date: Lapse of forfeiture restrictions on the 6,667 performance-based RSUs from this grant made on August 24, 2020. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040851 · doc4.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents the right to receive one share of the Registrant's common stock. F3 · derivative.exercise_date: Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020. F3 · derivative.expiration_date: Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Tax withholdingCommon Stock | 7,015 | $0.38 | $2,665.70 |
DisclosureSEC source: 0001209191-22-040851 · doc4.xml · nonDerivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,658 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 17:30 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionCommon Stock | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040851 · doc4.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Lapse of forfeiture restrictions on one third of the grant of the time-based restricted stock units ("RSUs") and on one third of the performance-based RSUs awarded on August 24, 2020. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 59,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 9 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F10 · derivative.exercise_date: Lapse of forfeiture restrictions on a discretionary retention award made on February 8, 2021. F10 · derivative.expiration_date: Lapse of forfeiture restrictions on a discretionary retention award made on February 8, 2021. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 19,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 8 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,408 Underlying: Common Stock · 19,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F9 · derivative.exercise_date: Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs in two equal installments on each of February 4, 2023 and 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F9 · derivative.expiration_date: Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs in two equal installments on each of February 4, 2023 and 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 19,704 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 7 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,408 Underlying: Common Stock · 19,704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F8 · derivative.exercise_date: Lapse of forfeiture on one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs in two equal installments on February 4, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. F8 · derivative.expiration_date: Lapse of forfeiture on one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs in two equal installments on February 4, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 84,270 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 6 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,270 Underlying: Common Stock · 84,270 shares Expires not disclosed F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F7 · derivative.exercise_date: Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2023, as long as the Reporting Person remains in continuous service during the vesting period. F7 · derivative.expiration_date: Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2023, as long as the Reporting Person remains in continuous service during the vesting period. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 187,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 5 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,250 Underlying: Common Stock · 187,250 shares Expires not disclosed F5 · security: Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. F6 · derivative.exercise_date: PRSU award with time-based vesting in three equal installments on each of February 4, 2023, 2024 and 2025, and performance-based vesting only if designated corporate goals are met. F6 · derivative.expiration_date: PRSU award with time-based vesting in three equal installments on each of February 4, 2023, 2024 and 2025, and performance-based vesting only if designated corporate goals are met. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 187,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,250 Underlying: Common Stock · 187,250 shares Expires not disclosed F3 · security: Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2023, 2024 and 2025, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2023, 2024 and 2025, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | GrantStock Options · Derivative | 222,500 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,500 Underlying: Common Stock · 222,500 shares Expires 2029-02-04 F2 · derivative.exercise_date: Vests one-third annually on each of February 4, 2023, 2024 and 2025, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement"). Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Tax withholdingCommon Stock | 26,711 | $0.80 | $21,368.80 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · nonDerivative · entry 2 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,006 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 17:20 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionCommon Stock | 98,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007514 · doc4.xml · nonDerivative · entry 1 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 19:14 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 6,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045188 · doc4.xml · derivative · entry 4 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Underlying: Common Stock · 6,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Lapse of forfeiture restrictions on the 6,667 performance-based RSUs from this grant made on August 24, 2020. F4 · derivative.expiration_date: Lapse of forfeiture restrictions on the 6,667 performance-based RSUs from this grant made on August 24, 2020. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 19:14 UTC | ASENSUS SURGICAL, INC. ASXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045188 · doc4.xml · derivative · entry 3 Shameze Rampertab · CIK 0001721810 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each RSU represents the right to receive one share of the Registrant's common stock. F3 · derivative.exercise_date: Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020. F3 · derivative.expiration_date: Lapse of forfeiture restrictions on the 10,000 time-based RSUs from this grant made on August 24, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.